Vaccination of Children following Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 1 SUPPL., 2008, Pages 54-58

  Small, Trudy ^a  

^a MSKCC ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENCTRA II; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; RITUXIMAB; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CD4 LYMPHOCYTE COUNT; DRUG SAFETY; HLA MATCHING; HOSPITAL READMISSION; HUMAN; IMMUNIZATION; IMMUNOCOMPETENCE; IMMUNOGENICITY; INFLUENZA VIRUS A; NONHUMAN; POSTHERPETIC NEURALGIA; REVACCINATION; SEROCONVERSION; STREPTOCOCCUS INFECTION; T CELL DEPLETION; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

CHILD; GUIDELINES AS TOPIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY; TREATMENT OUTCOME; VACCINATION;

EID: 37449017118     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.11.006     Document Type: Article

References (47)

1. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR 49 (2000) 1-128
2. Ljungman P., Engelhard D., de la Cámara R., et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT, 2005. Bone Marrow Transplant 35 (2005) 737-746
3. Machado C.M. Reimmunization after hematopoietic stem cell transplantation. Vaccine 4 (2005) 19-228
4. Al-Kasim F.A., Thornley I., Rolland, et al. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Br J Haematol 116 (2002) 483-490
5. -) marrow transplants from related and unrelated donors for children with acute leukemia transplanted in first or second remission. Blood 98 (2001) 674a
6. Alyea E.P., Weller E., Fisher D.C., et al. Comparable outcome with T-cell-depleted unrelated-donor versus related-donor allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 8 (2002) 601-607
7. Hansen J.A., Gooley T.A., Martin P.J., et al. Bone marrow transplantation from unrelated donors for patients with chronic myeloid leukemia. N Eng J Med 338 (1998) 962
8. Chown S.R., Marks D.I., Cornish J.M., et al. Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission. Br J Haematol 99 (1997) 36
9. Ada G. Vaccines and vaccinations. N Engl J Med 345 (2001) 1042-1053
10. Ljungman P., Wiklund-Hammarsten M., Duraj V., et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 162 (1990) 496-500
11. Ljungman P., Lewensohn-Fuchs I., Hammarstrom V., et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 84 (1994) 657-663
12. Ljungman P., Fridell E., Lonnqvist B., et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 159 (1989) 610-615
13. Centers for Disease Control and Prevention. Multistate Investigation of measles among adoptees from China-April 9, 2004. MMWR Morb Mortal Wkly Rep 53 (2004) 309-310
14. Parker A.A., Staggs W., Dayan W., et al. Implications of a measles outbreak in Indiana for sustained elimination of measles in the United States. N Engl J Med 355 (2006) 447-455
15. MMWR. Update: multi-state outbreak of mumps-United States, January 1-May 2. MMWR 55 (2006) 559-563
16. Greenberg D.P. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J 24 (2005) 721-728
17. Galil K., Lee B., Strine T., et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 347 (2002) 1909-1915
18. Engelhard D., Cordonnier C., Shaw P.J., et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 117 (2002) 444-450
19. Socie G., Salooja N., Cohen A., et al. Non-malignant late effects after allogeneic stem cell transplantation. Blood 101 (2003) 3373-3385
20. Chen C.S., Boeckh M., Seidel K., et al. Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation. Bone Marrow Transplant 32 (2003) 515-522
21. Machado C.M., Cardoso M.R., da Rocha I.F., Boas L.S., Dulley F.L., and Pannuti C.S. The benefit of influenza vaccination after bone marrow transplantation. Bone Marrow Transplant 36 (2005) 897-900
22. Steer C.B., Szer J., Sasadeusz J., Matthews J.P., Beresford J.A., and Grigg A. Varicella zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. Bone Marrow Transplant 25 (2000) 657-664
23. Koc Y., Miller K.B., Schenkein D.P., et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 6 (2000) 44-49
24. Kawasaki H., Takayama J., and Ohira M. Herpes zoster infection after bone marrow transplantation inchildren. J Pediatr 128 (1996) 353-356
25. Gershon A.A., Steinberg S.P., and Gelb L. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics 78 (1986) 757-762
26. Weinberg A., Horslen S.P., Kaufman S.S., et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 6 (2006) 565-568
27. Sauerbrei A., Prager J., Hengst U., Zintl F., and Wutzler P. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant 20 (1997) 381-383
28. Ljungman P., Duraj V., and Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 7 (1991) 89-93
29. Parkkali T., Stenvik M., Ruutu T., Hovi T., Volin L., and Ruutu P. Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 20 (1997) 663-668
30. Jaffe D., Papadopoulos E.B., Young J.W., et al. Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell transplantation (HCT). Blood 108 (2006) 2470-2475
31. Guinan E.C., Molrine D.C., Antin J.H., et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 57 (1994) 677-684
32. Pao M.K., Papadopoulos E.B., Kernan N.A., et al. Immunogenicity of haemophilus influenza and pneumococcal vaccines in related and unrelated transplant recipients. Blood 108 (2006) 178a
33. Parkkali T., Kayhty H., Ruutu T., Volin L., Eskola J., and Ruutu P. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplant 18 (1996) 961-967
34. Avanzini M.A., Carra A.M., Maccario R., et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol 15 (1995) 137-144
35. Storek J., Dawson M.A., and Lim L.C. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplant 33 (2004) 337-346
36. Small T.N., Keever C.A., Weiner-Fedus S., Heller G., O'Reilly R.J., and Flomenberg N. B cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B cell ontogeny. Blood 76 (1990) 1647-1656
37. Black S.B., Shinefield H.R., Hansen J., Elvin L., Laufer D., and Malinoski F. Post licensure evaluation of the effectiveness of 7 valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 20 (2001) 1105-1107
38. Molrine D.C., Antin J.H., Guinan E.C., et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 101 (2003) 831-836
39. Meisel R., Kuypers L., Dirksen U., et al. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. Blood 109 (2007) 2322-2326
40. Machado C.M. Reimmunization after bone marrow transplantation-current recommendations and perspectives. Braz J Med Biol Res 37 (2004) 151-158
41. Machado CM, Rocha IF, Diomede B, et al. Effectiveness of Hepatitis B vaccination and persistence of immunity after BMT. The Ninth International Symposium on Infections in the Immunocompromised Host. Assisi, Italy, June 23-26, 1997.
42. Avanzini M., Locatelli F., Santos C., et al. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27 B cells. Exp Hematol 33 (2005) 480-486
43. American Academy of Pediatrics. Committee on Infectious Diseases. Age for routine. Administration of the second dose of measles-mumps-rubella vaccine. Pediatrics 101 (1998) 129-133
44. King S.M., Saunders E.F., Petric M., and Gold R. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. Bone Marrow Transplant 17 (1996) 633-636
45. Bilukha O.O., and Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 54 (2005) 1-21
46. Villa L.L., Ault K.A., and Giuliano A.R. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine 24 (2006) 5571-5583
47. Broder K.R., Cortese M.M., Iskander J.K., et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55 (2006) 1-34